I'm neither the "brillance" or a "basher" on this
Post# of 154055
(Total Views: 590)
Posted On: 01/30/2022 10:23:35 AM
I'm neither the "brillance" or a "basher" on this board, but I'll take a stab at it.
In response to your first question, the FDA has seen plenty of evidence that LL works on HIV given the trials were successful, and they've seen additional evidence on how it works on Covid, mTNBC, NASH, etc. so there's no reason to shut down any trials.
In response to your second question, I don't believe NP's termination was related to any sec/doj findings given there's been no charges. If there were, we would have heard about it by now because that would have been a material event. Additionally, that wouldn't be a reason for withholding the 700mg NASH results for over a month now, which I think WAS related to his termination. I think it's too coincidental they were expecting to get the results in late Dec, then announced a conf call for Jan 13 to discuss NASH (after announcing they planned to send the results to numerous BPs), and then suddenly cancelled the call just hours prior to the call, and ~2 weeks later terminated NP. I don't see how the sec/doj had anything to do with this timeline of events. IMO, I'm expecting major news soon that will put our financial problems behind us.
In response to your first question, the FDA has seen plenty of evidence that LL works on HIV given the trials were successful, and they've seen additional evidence on how it works on Covid, mTNBC, NASH, etc. so there's no reason to shut down any trials.
In response to your second question, I don't believe NP's termination was related to any sec/doj findings given there's been no charges. If there were, we would have heard about it by now because that would have been a material event. Additionally, that wouldn't be a reason for withholding the 700mg NASH results for over a month now, which I think WAS related to his termination. I think it's too coincidental they were expecting to get the results in late Dec, then announced a conf call for Jan 13 to discuss NASH (after announcing they planned to send the results to numerous BPs), and then suddenly cancelled the call just hours prior to the call, and ~2 weeks later terminated NP. I don't see how the sec/doj had anything to do with this timeline of events. IMO, I'm expecting major news soon that will put our financial problems behind us.
Quote:
I have two simple questions for all the brilliance on the board, especially the bashers, If leronlimab was so worthless/ineffective, wouldn’t FDA have shut down and ended any trails and ongoing trails long ago. Also, wouldn’t cydy have to pr/schedule 8 any sec/doj findings that lead to the termination of NP if that were the case, Wouldn’t sec/doj make findings/charges as well.
(22)
(0)CytoDyn Inc (CYDY) Stock Research Links
My comments are just my opinions and should NOT be taken as investment advice.